Trial Details

COMPLETED
Basic Information
Clinical ID c958
Identifier NCT02506179
Trial Title Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions -
Participant Information
Sponsor AbbVie
City Calgary
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2015-08-18
Primary Completion Date 2020-02-10
Completion Date 2020-02-10